E
From left, David McCready, Sanjay Pathak, guest speaker Kim Eagle, John Byrne and Mandeep Mehra

A Vision for the Future: BWH’s Heart & Vascular Center

BWH leadership and cardiovascular staff came together Jan. 22 to celebrate the launch of BWH’s Heart & Vascular Center, a fully integrated and aligned service dedicated to delivering life-giving breakthroughs.

E

Greek and US Experts Talk Vascular Biology

An international symposium assembled at BWH to discuss heart disease.

E
John Byrne, MD, and Mandeep Mehra, MD

Cardiogenic Shock Team Provides Rapid Coordinated Response

The Center for Advanced Heart Disease at BWH is taking an innovative approach to caring for some of its sickest patients.

E
Paul M. Ridker, MD, director of the BWH Center for Cardiovascular Disease Prevention (pictured right), is leading the NIH-funded Cardiovascular Inflammation Reduction Trial with a team of BWH faculty including Samuel Z. Goldhaber, MD, director of the BWH Thrombosis Research Group (pictured left).

Novel Trial Evaluates Inflammation Reduction to Prevent Recurrent Cardiovascular Events

The Cardiovascular Inflammation Reduction Trial studies whether a drug used to treat rheumatoid arthritis can also reduce recurrent cardiovascular events.

E
Guillermo García-Cardeña

Vascular Ingenuity

Research Roundup

E
David E. Cohen

Understanding Signals

Research Roundup

E
blumberg

Novel Drug Discovery Leads to Company, Acquisition

Richard Blumberg, MD, humbly refers to his hemophilia drug discovery as “a beautiful mistake.”